Cargando…
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in hum...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Environmental Health Perspectives
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791490/ https://www.ncbi.nlm.nih.gov/pubmed/31487205 http://dx.doi.org/10.1289/EHP5297 |
_version_ | 1783458985933799424 |
---|---|
author | Noyes, Pamela D. Friedman, Katie Paul Browne, Patience Haselman, Jonathan T. Gilbert, Mary E. Hornung, Michael W. Barone, Stan Crofton, Kevin M. Laws, Susan C. Stoker, Tammy E. Simmons, Steven O. Tietge, Joseph E. Degitz, Sigmund J. |
author_facet | Noyes, Pamela D. Friedman, Katie Paul Browne, Patience Haselman, Jonathan T. Gilbert, Mary E. Hornung, Michael W. Barone, Stan Crofton, Kevin M. Laws, Susan C. Stoker, Tammy E. Simmons, Steven O. Tietge, Joseph E. Degitz, Sigmund J. |
author_sort | Noyes, Pamela D. |
collection | PubMed |
description | BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, in vitro assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented. OBJECTIVES: We present an adverse outcome pathway (AOP) network to link data derived from in vitro assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from in vivo testing. We examine the role of new in vitro technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism. DISCUSSION: There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of in vitro assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. https://doi.org/10.1289/EHP5297 |
format | Online Article Text |
id | pubmed-6791490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Environmental Health Perspectives |
record_format | MEDLINE/PubMed |
spelling | pubmed-67914902019-11-06 Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches Noyes, Pamela D. Friedman, Katie Paul Browne, Patience Haselman, Jonathan T. Gilbert, Mary E. Hornung, Michael W. Barone, Stan Crofton, Kevin M. Laws, Susan C. Stoker, Tammy E. Simmons, Steven O. Tietge, Joseph E. Degitz, Sigmund J. Environ Health Perspect Commentary BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, in vitro assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented. OBJECTIVES: We present an adverse outcome pathway (AOP) network to link data derived from in vitro assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from in vivo testing. We examine the role of new in vitro technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism. DISCUSSION: There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of in vitro assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. https://doi.org/10.1289/EHP5297 Environmental Health Perspectives 2019-09-05 /pmc/articles/PMC6791490/ /pubmed/31487205 http://dx.doi.org/10.1289/EHP5297 Text en EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. |
spellingShingle | Commentary Noyes, Pamela D. Friedman, Katie Paul Browne, Patience Haselman, Jonathan T. Gilbert, Mary E. Hornung, Michael W. Barone, Stan Crofton, Kevin M. Laws, Susan C. Stoker, Tammy E. Simmons, Steven O. Tietge, Joseph E. Degitz, Sigmund J. Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title | Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title_full | Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title_fullStr | Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title_full_unstemmed | Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title_short | Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches |
title_sort | evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791490/ https://www.ncbi.nlm.nih.gov/pubmed/31487205 http://dx.doi.org/10.1289/EHP5297 |
work_keys_str_mv | AT noyespamelad evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT friedmankatiepaul evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT brownepatience evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT haselmanjonathant evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT gilbertmarye evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT hornungmichaelw evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT baronestan evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT croftonkevinm evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT lawssusanc evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT stokertammye evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT simmonssteveno evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT tietgejosephe evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches AT degitzsigmundj evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches |